← Back to Search

Other

OLE Therapy with The MetaNeb® System for Coronavirus

N/A
Recruiting
Research Sponsored by Hill-Rom
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time frame begins when the patient is first started on heated high-flow oxygen therapy and ends when they are ready for discharge from the hospital. expected time is a a few days but not expected to exceed 3 weeks.
Awards & highlights

Study Summary

This study is evaluating whether a new device may help prevent the need for intubation in patients with COPD.

Eligible Conditions
  • Coronavirus
  • Oscillatory Lung Expansion
  • COVID-19

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time frame begins when the patient is first started on heated high-flow oxygen therapy and ends when they are ready for discharge from the hospital. expected time is a a few days but not expected to exceed 3 weeks.
This trial's timeline: 3 weeks for screening, Varies for treatment, and time frame begins when the patient is first started on heated high-flow oxygen therapy and ends when they are ready for discharge from the hospital. expected time is a a few days but not expected to exceed 3 weeks. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hospital Length of Stay

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: OLE Therapy with The MetaNeb® SystemExperimental Treatment1 Intervention
Subjects in the active treatment group will receive OLE therapy with The MetaNeb® System following the labeled instructions for the device.
Group II: Control GroupActive Control1 Intervention
The airway clearance regimen for subjects in the control group will be collected from the medical record.This information will be retrospectively collected from patients treated with standard care with no OLE therapy. Subjects in the control group will be identified from the population of patients previously admitted to the two study sites with COVID-19 infection who required invasive mechanical ventilation but were not treated with OLE therapy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MetaNeb® System
2016
N/A
~420

Find a Location

Who is running the clinical trial?

Emory UniversityOTHER
1,638 Previous Clinical Trials
2,560,526 Total Patients Enrolled
Northwestern UniversityOTHER
1,585 Previous Clinical Trials
917,225 Total Patients Enrolled
Hill-RomLead Sponsor
33 Previous Clinical Trials
2,863 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Oscillation and Lung Expansion Therapy in Patients With COVID-19
2020. "Oscillation and Lung Expansion Therapy in Patients With COVID-19". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04582214.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top